We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Bladder Cancer

Journal Scan / Research · July 01, 2021

Feasibility of Preoperative Pembrolizumab Before Radical Nephroureterectomy in Patients With High-Risk UTUC

Urologic Oncology: Seminars & Original Investigations

 

Additional Info

Urologic Oncology: Seminars & Original Investigations
A Feasibility Study of Preoperative Pembrolizumab Before Radical Nephroureterectomy in Patients With High-Risk, Upper Tract Urothelial Carcinoma: PURE-02
Urol. Oncol 2021 Jun 16;[EPub Ahead of Print], A Necchi, A Martini, D Raggi, V Cucchiara, M Colecchia, R Lucianò, L Villa, E Mazzone, G Basile, S Scuderi, F Pederzoli, M Bandini, F Barletta, A Larcher, U Capitanio, A Salonia, A Briganti, JS Ross, A Messina, F Montorsi

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading